| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.007 | 0.9 |